Summary
Procedures to evaluate lymph nodes before lung cancer therapy, including endobronchial guided nodal aspiration and mediastinoscopy, can help diagnose and stage the patient effectively. Research findings demonstrate, however, that these procedures are underutilized overall or employed in a highly variable fashion. In this STS webinar, an expert panel of pulmonologists and thoracic surgeons discusses the changing role of pretreatment nodal staging to include diagnosis, staging, and acquisition of sufficient tissue for biomarker testing.
Moderators
Janet P. Edwards, MD, MPH
University of Calgary
Calgary, AB, Canada
Farhood Farjah, MD, MPH
University of Washington
Seattle, WA
Panelists
Nathaniel R. Evans III, MD
Thomas Jefferson University
Philadelphia, PA
Anne V. Gonzalez, MD, MSc
Research Institute of McGill University Health Centre
Montreal, QC, Canada
Moishe A. Liberman, MD, PhD
University of Montreal Health Centre
Montreal, QC, Canada